Docoh
Loading...

FATE Fate Therapeutics

GRANT
Utility
Stem cell culture media and methods of enhancing cell survival
5 Oct 21
The invention provides improved methods for preparing hematopoietic cells for transplantation and the resulting improved hematopoietic cell compositions.
Betsy Denise Rezner
Filed: 7 Mar 18
GRANT
Utility
Compositions and methods for immune cell modulation in adoptive immunotherapies
24 Aug 21
Compounds that either produced a higher proportion or greater absolute number of phenotypically identified nave, stem cell memory, central memory T cells, adaptive NK cells, and type I NKT cells are identified.
Jonathan Rosen, Betsy Rezner, Bahram Valamehr, Ryan Bjordahl, Eigen Peralta
Filed: 20 Jan 17
APP
Utility
Methods and Compositions for Inducing Hematopoietic Cell Differentiation
29 Jul 21
The invention provides culture platforms, cell media, and methods of differentiating pluripotent cells into hematopoietic cells.
Bahram Valamehr, Raedun Clarke, Ryan Bjordahl
Filed: 12 Mar 21
GRANT
Utility
Genomic engineering of pluripotent cells
27 Jul 21
Provided are methods and compositions for obtaining genome-engineered iPSCs, and derivative cells with stable and functional genome editing at selected sites.
Bahram Valamehr, Ramzey Abujarour, Tom Tong Lee, Weijie Lan, Raedun Clarke, Ryan Bjordahl
Filed: 9 Apr 19
APP
Utility
Methods and Compositions for Inducing Hematopoietic Cell Differentiation
22 Jul 21
The invention provides culture platforms, cell media, and methods of differentiating pluripotent cells into hematopoietic cells.
Bahram Valamehr, Raedun Clarke, Ryan Bjordahl
Filed: 11 Mar 21
GRANT
Utility
Enhanced stem cell composition
6 Jul 21
The invention provides improved methods for cell therapy.
Daniel Shoemaker, David Robbins, John D. Mendlein, Caroline Desponts
Filed: 12 Dec 18
APP
Utility
Minimal Volume Reprogramming of Mononuclear Cells
1 Jul 21
The invention provides compositions and methods for reprogramming minimal volumes of mononuclear cells.
Peter Flynn, Bahram Valamehr
Filed: 23 Feb 21
APP
Utility
Enhanced Immune Effector Cells and Use Thereof
17 Jun 21
Provided are methods and compositions for obtaining functionally enhanced derivative effector cells obtained from directed differentiation of genomically engineered iPSCs.
Bahram VALAMEHR, Ryan BJORDAHL, Jode GOODRIDGE, Tom Tong LEE
Filed: 19 Feb 21
APP
Utility
Immune Effector Cell Engineering and Use Thereof
3 Jun 21
Provided are methods and compositions for obtaining functionally enhanced derivative effector cells obtained from directed differentiation of genomically engineered iPSCs.
Bahram VALAMEHR, Tom Tong LEE, Ryan BJORDAHL, Jode GOODRIDGE
Filed: 29 Jan 21
APP
Utility
Enhanced Immune Effector Cells and Use Thereof
3 Jun 21
Provided are methods and compositions for obtaining functionally enhanced derivative effector cells obtained from directed differentiation of genomically engineered iPSCs.
Bahram VALAMEHR, Ryan BJORDAHL, Jode GOODRIDGE, Tom Tong LEE
Filed: 11 Jan 21
APP
Utility
Enhanced Immune Effector Cells and Use Thereof
25 Mar 21
Provided are methods and compositions for obtaining functionally enhanced derivative effector cells obtained from directed differentiation of genomically engineered iPSCs.
Bahram VALAMEHR, Ryan BJORDAHL, Jode GOODRIDGE, Tom Tong LEE
Filed: 21 Dec 18
GRANT
Utility
Minimal volume reprogramming of mononuclear cells
23 Mar 21
The invention provides compositions and methods for reprogramming minimal volumes of mononuclear cells.
Peter Flynn, Bahram Valamehr
Filed: 13 Jun 18
APP
Utility
Cell Culture Platform for Single Cell Sorting and Enhanced Reprogramming of Ipscs
18 Mar 21
The invention provides cell culture conditions for culturing stem cells, including feeder-free conditions for generating and culturing human induced pluripotent stem cells (iPSCs).
Bahram Valamehr, Ramzey Abujarour, Peter Flynn
Filed: 30 Sep 20
GRANT
Utility
Methods and compositions for inducing hematopoietic cell differentiation
16 Mar 21
The invention provides culture platforms, cell media, and methods of differentiating pluripotent cells into hematopoietic cells.
Bahram Valamehr, Raedun Clarke, Ryan Bjordahl
Filed: 2 Oct 20
APP
Utility
Methods and Compositions for Inducing Hematopoietic Cell Differentiation
4 Mar 21
The invention provides culture platforms, cell media, and methods of differentiating pluripotent cells into hematopoietic cells.
Bahram Valamehr, Raedun Clarke, Ryan Bjordahl
Filed: 2 Oct 20
GRANT
Utility
Enhanced immune effector cells and use thereof
23 Feb 21
Provided are methods and compositions for obtaining functionally enhanced derivative effector cells obtained from directed differentiation of genomically engineered iPSCs.
Bahram Valamehr, Ryan Bjordahl, Jode Goodridge, Tom Tong Lee
Filed: 19 Sep 19
APP
Utility
Methods and Compositions for Inducing Hematopoietic Cell Differentiation
28 Jan 21
The invention provides culture platforms, cell media, and methods of differentiating pluripotent cells into hematopoietic cells.
Bahram Valamehr, Raedun Clarke, Ryan Bjordahl
Filed: 2 Oct 20
APP
Utility
Engineered Immune Effector Cells and Use Thereof
28 Jan 21
Provided are methods and compositions for obtaining functionally enhanced derivative effector cells obtained from directed differentiation of genomically engineered iPSCs.
Bahram VALAMEHR, Ryan BJORDAHL, Jode GOODRIDGE, Tom Tong LEE
Filed: 28 Mar 19
APP
Utility
IMMUNOTHERAPIES USING ENHANCED iPSC DERIVED EFFECTOR CELLS
21 Jan 21
Provided are methods and compositions for obtaining functionally enhanced derivative effector cells obtained from directed differentiation of genomically engineered iPSCs.
Bahram VALAMEHR, Ryan BJORDAHL, Tom Tong LEE, Svetlana GAIDAROVA
Filed: 30 Nov 18
GRANT
Utility
Methods and compositions for inducing hematopoietic cell differentiation
7 Dec 20
The invention provides culture platforms, cell media, and methods of differentiating pluripotent cells into hematopoietic cells.
Bahram Valamehr, Raedun Clarke, Ryan Bjordahl
Filed: 25 Jul 16
Patents are sorted by USPTO publication date, most recent first